Press releases archive - Pronova BioPharma

You are here: Home / News / Press releases archive

Press releases archive

5. Jul 2010 09:07:
Adds another patent to the Orange Book listing of Omacor®/Lovaza(TM)
16. Jun 2010 15:15:
Mandatory notification of trade
15. Jun 2010 10:09:
Mandatory notification of trade
14. Jun 2010 08:34:
Pronova BioPharma revises shipment outlook for 2010
3. Jun 2010 16:10:
Guidelines for remuneration to senior management
7. May 2010 13:57:
Minutes from the ordinary general meeting
7. May 2010 07:00:
Strengthened position following intellectual property and regulatory approvals
27. Apr 2010 14:32:
Presentation of first quarter 2010 results
27. Apr 2010 14:26:
Annual overview
20. Apr 2010 10:52:
Pronova BioPharma achieved FDA regulatory approval for the Kalundborg manufacturing plant
20. Apr 2010 06:58:
Italian court ceases patent litigation dispute
16. Apr 2010 08:00:
Notice of ordinary general meeting
16. Apr 2010 08:00:
Annual report 2009
16. Apr 2010 07:00:
Ruling by the German Federal High Court of Justice
25. Mar 2010 07:47:
Presentation at Nordic Healthcare Seminar in Stockholm
12. Feb 2010 07:00:
A strong financial and operational performance in 2009
5. Feb 2010 16:15:
Presentation of fourth quarter 2009 results
8. Jan 2010 09:00:
Presentation at the SEB Investor Conference in Copenhagen
14. Dec 2009 08:15:
TAK-085 Entered into Phase 3 Clinical Programs
7. Dec 2009 08:47:
Financial calender 2010 for Pronova BioPharma ASA
25. Nov 2009 15:06:
Regulatory approval in EU achieved for the Kalundborg manufacturing plant
20. Nov 2009 14:22:
MANDITORY NOTIFICATION OF TRADE
20. Nov 2009 07:04:
Pronova BioPharma ASA presented at "Aksjedagen Norge" 2009
13. Nov 2009 15:54:
MANDITORY NOTIFICATION OF TRADE IN PRONOVA BIOPHARMA
6. Nov 2009 12:25:
Mandatory notification of trade
3. Nov 2009 07:00:
Well positioned to realise long term growth potential with doubled production capacity
28. Oct 2009 10:58:
Presentation of third quarter 2009 results
7. Oct 2009 13:22:
Organisational changes
30. Sep 2009 15:50:
Norwegian pharmaceutical company opens new Danish plant
29. Sep 2009 10:37:
PRONOVA BIOPHARMA GRANTED GMP CERTIFICATION IN DENMARK
21. Sep 2009 21:30:
Pronova BioPharma ASA presented at the UBS Global Life Sciences Conference 2009 21 September
17. Sep 2009 12:36:
Pronova BioPharma ASA to present at the UBS Global Life Sciences Conference 2009 21 September
9. Sep 2009 10:30:
Capital markets day: presentation material and CEO introduction
8. Sep 2009 16:58:
Pronova BioPharma receives 2009 Frost & Sullivan Award for Excellence in Financial & Risk Management
14. Aug 2009 07:24:
Maintaining operational momentum
13. Aug 2009 12:49:
Capital Markets Day in Kalundborg, Wednesday 9 September 2009
7. Aug 2009 16:36:
Presentation of second quarter and half year 2009 results
2. Jul 2009 10:51:
Mandatory notification of trade
30. Jun 2009 16:49:
Pronova BioPharma appoints Morten Jurs as new CEO
22. Jun 2009 08:30:
Capital markets day Wednesday 9 September 2009
14. May 2009 11:06:
MANDATORY NOTIFICATION OF TRADE
7. May 2009 07:49:
Mandatory notification of trade
6. May 2009 07:00:
Mandatory notification of trade, 5 May, 2009
5. May 2009 14:18:
Minutes from the annual general meeting
5. May 2009 07:00:
Excellent production performance gave strong start to 2009
30. Apr 2009 10:14:
Pronova BioPharma Norge AS files Lawsuit against Apotex, Inc. and Par Pharmaceutical, Inc. relating to LovazaTM
29. Apr 2009 16:02:
The nomination committee's recommendation of election of board members to Pronova BioPharma ASA (OSE: PRON.OL)
27. Apr 2009 10:35:
Presentation of first quarter 2009 results
24. Apr 2009 08:00:
Pronova BioPharma Norge AS files lawsuit against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. relating to Lovaza(TM).
14. Apr 2009 17:02:
NOTICE OF ANNUAL GENERAL MEETING
3. Apr 2009 15:38:
Pronova BioPharma presented at the Odin Fund Event in London, 31 March 2009
31. Mar 2009 09:48:
Approved annual accounts for 2008
30. Mar 2009 17:00:
Findings in the OMEGA study presented
26. Mar 2009 15:45:
Pronova BioPharma ASA to present at the 14th. Annual Carnegie Nordic Health Care Seminar in Stockholm, 26 March 2009
24. Mar 2009 09:19:
Pronova BioPharma receives Lovaza(TM) Paragraph IV Notice Letter from Apotex Inc.
20. Mar 2009 12:45:
Pronova BioPharma receives Lovaza(TM) Paragraph IV Notice Letter from Par Pharmaceutical Inc.
12. Mar 2009 15:08:
Pronova receives Lovaza(TM) Paragraph IV Notice Letter from Teva
13. Feb 2009 07:00:
Q4 results: Strong revenue growth for Pronova BioPharma
6. Feb 2009 12:11:
Presentation of fourth quarter 2008 results
2. Feb 2009 12:30:
Gjenopptar drift av bioreaktor i renseanlegg
9. Jan 2009 15:11:
Pronova BioPharma ASA : Presentation material
9. Jan 2009 14:32:
Annual Overview
9. Jan 2009 14:00:
Pronova BioPharma announces changes in the group's management team
6. Jan 2009 09:00:
Pronova BioPharma ASA files a Terminal Disclaimer
2. Dec 2008 16:38:
Financial Calender 2009 for Pronova BioPharma ASA
17. Nov 2008 12:44:
Pronova BioPharma share buy back
17. Nov 2008 07:00:
Pronova BioPharma share buy back
13. Nov 2008 07:00:
Pronova BioPharma share buy back
12. Nov 2008 07:00:
Pronova BioPharma share buy back
11. Nov 2008 08:58:
Pronova BioPharma share buy back
11. Nov 2008 08:41:
Study Demonstrating Lovaza/Omacor Co-administered with Atorvastatin Reduces Non-HDL Cholesterol to be presented at AHA
10. Nov 2008 11:34:
MANDATORY NOTIFICATION OF TRADE
7. Nov 2008 15:25:
MANDATORY NOTIFICATION OF TRADE
5. Nov 2008 07:00:
Pronova BioPharma announces Strategic Supply Agreement for a Fixed Dose Combination Product with Omacor and Simvastatin
4. Nov 2008 14:26:
MANDATORY NOTIFICATION OF TRADE - corrected announcement
4. Nov 2008 14:10:
MANDATORY NOTIFICATION OF TRADE
4. Nov 2008 07:05:
Continued strong growth for Pronova BioPharma
4. Nov 2008 07:00:
Pronova BioPharma appoints Per-Oluf Olsen as new CEO
23. Oct 2008 17:40:
Presentation of third quarter results 2008
16. Sep 2008 09:35:
Presentation at UBS Global Life Sciences Conference
31. Aug 2008 15:32:
Significant Clinical Data presented at ESC: OMACOR® Reduces Mortality and Hospitalisations in Patients with Congestive Heart Failure
28. Aug 2008 14:00:
Pronova to host a webcast regarding the GISSI-HF study 1 September
22. Aug 2008 12:00:
Announces Third Party Agreement for Sourcing of Intermediaries
20. Aug 2008 08:00:
Pronova BioPharma Announces Ruling by the District Court of Rome, Italy
5. Aug 2008 07:00:
Q2 2008: Pronova BioPharma's best quarter
28. May 2008 11:48:
Presentation material to be used 28-29 May 2008
26. May 2008 10:52:
Pronova BioPharma ASA to present at the 13th. Annual Carnegie Nordic Health Care Seminar in Stockholm, May 28 2008 and at the UBS Global Specialty Pharmaceutical and Generics Conference in London, May 29 2008.
15. May 2008 12:06:
CAPITAL MARKETS DAY - PRESENTATIONS PART 3
15. May 2008 12:05:
CAPITAL MARKETS DAY - PRESENTATIONS PART 2
15. May 2008 12:05:
CAPITAL MARKETS DAY - PRESENTATIONS PART 1
6. May 2008 14:43:
Minutes from ordinary general meeting 6 May 2008
6. May 2008 07:00:
Extensive growth in all end-user markets
28. Apr 2008 16:26:
Presentation of first quarter results 2008
24. Apr 2008 12:37:
Capital markets day Thursday 15 May 2008
15. Apr 2008 23:10:
Revision of amortisation profiles
15. Apr 2008 23:04:
ANNUAL REPORT 2007
15. Apr 2008 22:57:
NOTICE OF ANNUAL GENERAL MEETING
15. Apr 2008 22:57:
INNKALLING TIL ORDINÆR GENERALFORSAMLING
28. Mar 2008 15:28:
Updated financial calendar - capital markets day 15 May 2008
12. Feb 2008 07:00:
Strong and profitable growth continued in Q4
4. Feb 2008 13:16:
Presentation of fourth quarter results 2007
4. Jan 2008 15:09:
Investor Presentations
20. Dec 2007 08:15:
GlaxoSmithKline completes acquisition of Reliant Pharmaceuticals
14. Dec 2007 08:27:
PRONOVA BIOPHARMA AND FMC CORPORATION TO DEVELOP NEW ALGINATE-BASED CAPSULE PRODUCTION
11. Dec 2007 15:07:
Pronova BioPharma selects NNE Pharmaplan to build new plant
27. Nov 2007 16:21:
Patent Court Ruling in Germany
21. Nov 2007 17:05:
GlaxoSmithKline announces USD 1.65 billion of acquisition Reliant Pharmaceutical
22. Oct 2007 07:49:
Pronova BioPharma to expand manufacturing capabilities and double capacity
2. Nov 2005 12:54:
Takeda and Pronova Biocare to Agree an License and Supply Agreement on Omacor®, Treatment for Hypertriglyceridemia
1. Apr 2005 12:49:
Ferd Private Equity Fund acquires Hydro's remaining shares in Pronova Biocare AS
22. Dec 2003 12:47:
Ferd Private Equity's second acquisition: Pronova Biocare AS